TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A HETEROBIARYL MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR
申请人:Bristol-Myers Squibb Company
公开号:US20190055246A1
公开(公告)日:2019-02-21
Compounds having a structure according to formula (I) or (II)
where R
1
, R
2
, and Ar are as defined herein, are agonists for the Toll-like receptor 7 (TLR7) and can be used as adjuvants for stimulating the immune system. Some such compounds can be used in conjugates for targeted delivery to the organ or tissue of intended action.